(FILES) This file photo taken on August 9, 2022 shows vials of the JYNNEOS Monkeypox vaccine are prepared at a pop-up vaccination clinic in Los Angeles, California. Shares of the pharmaceutical laboratories of Bavarian Nordic in Denmark, which manufactures a specific vaccine against the mpox, jumped up on August 15, 2024 following the decision of the World Organization of Health WHO to consider the resurgence of monkeypox cases together with an urgent need for health care in the world. A surging mpox outbreak in Africa, which was declared an emergency by the continent's health agency on August 13, is being driven by a new, more transmissible strain of the virus. The Africa Centres for Disease Control and Prevention (Africa CDC) declared its first-ever Public Health Emergency of Continental Security (PHECS) for the deadly disease. (Photo by Patrick T. FALLON / AFP)
Die aktuelle Generation der Pockenimpfstoffe schützt auch gegen Affenpocken - vor allem gegen schwere Erkrankung. © AFP / Patrick T. Fallon

Mehr zum Thema Affenpocken